{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T06:13:59Z","timestamp":1784268839675,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,3,9]],"date-time":"2017-03-09T00:00:00Z","timestamp":1489017600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s10549-017-4181-0","type":"journal-article","created":{"date-parts":[[2017,3,9]],"date-time":"2017-03-09T06:59:59Z","timestamp":1489042799000},"page":"383-390","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients"],"prefix":"10.1007","volume":"163","author":[{"given":"Beth","family":"Crawford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie B.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Sittler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"van den Akker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salina","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofri","family":"Leitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elad","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"van \u2019t Veer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,9]]},"reference":[{"key":"4181_CR1","doi-asserted-by":"publisher","first-page":"12629","DOI":"10.1073\/pnas.1007983107","volume":"107","author":"T Walsh","year":"2010","unstructured":"Walsh T, Lee MK, Casadei S et al (2010) Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing. Proc Natl Acad Sci USA 107:12629\u201312633","journal-title":"Proc Natl Acad Sci USA"},{"key":"4181_CR2","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1200\/JCO.2013.53.6607","volume":"32","author":"AW Kurian","year":"2014","unstructured":"Kurian AW, Hare EE, Mills MA et al (2014) Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment. J Clin Oncol 32:2001\u20132009","journal-title":"J Clin Oncol"},{"key":"4181_CR3","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ygyno.2015.01.537","volume":"137","author":"LE Minion","year":"2015","unstructured":"Minion LE, Dolinsky JS, Chase DM et al (2015) Hereditary predisposition to ovarian cancer, looking beyond BRCA1\/BRCA2. Gynecol Oncol 137:86\u201392","journal-title":"Gynecol Oncol"},{"key":"4181_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/cncr.29010","volume":"121","author":"N Tung","year":"2015","unstructured":"Tung N, Battelli C, Allen B et al (2015) Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. Cancer 121:25\u201333","journal-title":"Cancer"},{"key":"4181_CR5","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/1471-2164-12-184","volume":"12","author":"AS Nord","year":"2011","unstructured":"Nord AS, Lee M, King M-C, Walsh T (2011) Accurate and exact CNV identification from targeted high-throughput sequence data. BMC Genom 12:184","journal-title":"BMC Genom"},{"key":"4181_CR6","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.cancergen.2013.11.002","volume":"206","author":"HJ Abel","year":"2013","unstructured":"Abel HJ, Duncavage EJ (2013) Detection of structural DNA variation from next generation sequencing data: a review of informatic approaches. Cancer Genet 206:432\u2013440","journal-title":"Cancer Genet"},{"issue":"Suppl 11","key":"4181_CR7","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/1471-2105-14-S11-S1","volume":"14","author":"M Zhao","year":"2013","unstructured":"Zhao M, Wang Q, Wang Q et al (2013) Computational tools for copy number variation (CNV) detection using next-generation sequencing data: features and perspectives. BMC Bioinform 14(Suppl 11):S1","journal-title":"BMC Bioinform"},{"key":"4181_CR8","doi-asserted-by":"publisher","first-page":"18032","DOI":"10.1073\/pnas.1115052108","volume":"108","author":"T Walsh","year":"2011","unstructured":"Walsh T, Casadei S, Lee MK et al (2011) Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing. Proc Natl Acad Sci USA 108:18032\u201318037","journal-title":"Proc Natl Acad Sci USA"},{"key":"4181_CR9","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/gim.2014.40","volume":"16","author":"H LaDuca","year":"2014","unstructured":"LaDuca H, Stuenkel AJ, Dolinsky JS et al (2014) Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2000 patients. Genet Med 16:830\u2013837","journal-title":"Genet Med"},{"key":"4181_CR10","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s10689-014-9741-4","volume":"13","author":"CG Selkirk","year":"2014","unstructured":"Selkirk CG, Vogel KJ, Newlin AC et al (2014) Cancer genetic testing panels for inherited cancer susceptibility: the clinical experience of a large adult genetics practice. Fam Cancer 13:527\u2013536","journal-title":"Fam Cancer"},{"key":"4181_CR11","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","volume":"372","author":"DF Easton","year":"2015","unstructured":"Easton DF, Pharoah PDP, Antoniou AC et al (2015) Gene-panel sequencing and the prediction of breast-cancer risk. N Engl J Med 372:2243\u20132257","journal-title":"N Engl J Med"},{"key":"4181_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/cge.12315","volume":"86","author":"JM Eggington","year":"2014","unstructured":"Eggington JM, Bowles KR, Moyes K et al (2014) A comprehensive laboratory-based program for classification of variants of uncertain significance in hereditary cancer genes. Clin Genet 86:229\u2013237","journal-title":"Clin Genet"},{"key":"4181_CR13","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1001\/jamaoncol.2015.2690","volume":"1","author":"A Desmond","year":"2015","unstructured":"Desmond A, Kurian AW, Gabree M et al (2015) Clinical actionability of multigene panel testing for hereditary breast and ovarian cancer risk assessment. JAMA Oncol 1:943\u2013951","journal-title":"JAMA Oncol"},{"key":"4181_CR14","unstructured":"(2016) NCCN Genetic\/Familial High-Risk Assessment: Breast and Ovarian 2016. National Comprehensive Cancer Network"},{"key":"4181_CR15","doi-asserted-by":"crossref","unstructured":"Yurgelun MB, Allen B, Kaldate RR, Bowles K, Roa B, Wenstrup RJ, Hartman A-R, Syngal S (2014) Multigene panel testing in patients suspected to have Lynch syndrome. Clinical science symposium, next-generation sequencing panels for cancer risk assessment. Presented at scientific symposia","DOI":"10.1200\/jco.2014.32.15_suppl.1509"},{"key":"4181_CR16","unstructured":"Everett JN, Gustafson SL, Corey BA, Saraiya DS, Stoffel EM, Moyes K, Saam J, Abbott B, Raymond VM (2013) Prevalence of Lynch Syndrome and HBOC among patients with Primary Endometrial and Ovarian Cancers. Presented at scientific symposia"},{"key":"4181_CR17","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405\u2013424","journal-title":"Genet Med"},{"key":"4181_CR18","first-page":"7608","volume":"61","author":"T D\u00f6rk","year":"2001","unstructured":"D\u00f6rk T, Bendix R, Bremer M et al (2001) Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients. Cancer Res 61:7608\u20137615","journal-title":"Cancer Res"},{"key":"4181_CR19","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1086\/302746","volume":"66","author":"A Broeks","year":"2000","unstructured":"Broeks A, Urbanus JH, Floore AN et al (2000) ATM-heterozygous germline mutations contribute to breast cancer-susceptibility. Am J Hum Genet 66:494\u2013500","journal-title":"Am J Hum Genet"},{"key":"4181_CR20","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1093\/annonc\/mdh352","volume":"15","author":"J Rogozi\u0144ska-Szczepka","year":"2004","unstructured":"Rogozi\u0144ska-Szczepka J, Utracka-Hutka B, Grzybowska E et al (2004) BRCA1 and BRCA2 mutations as prognostic factors in bilateral breast cancer patients. Ann Oncol 15:1373\u20131376","journal-title":"Ann Oncol"},{"key":"4181_CR21","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/bjc.2013.792","volume":"110","author":"C Petridis","year":"2014","unstructured":"Petridis C, Shinomiya I, Kohut K et al (2014) Germline CDH1 mutations in bilateral lobular carcinoma in situ. Br J Cancer 110:1053\u20131057","journal-title":"Br J Cancer"},{"key":"4181_CR22","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/bcr3159","volume":"14","author":"D Ding","year":"2012","unstructured":"Ding D, Zhang Y, He X et al (2012) Frequency of the CHEK2 1100delC mutation among women with early-onset and bilateral breast cancer. Breast Cancer Res 14:401","journal-title":"Breast Cancer Res"},{"key":"4181_CR23","doi-asserted-by":"publisher","first-page":"4308","DOI":"10.1200\/JCO.2012.42.7336","volume":"30","author":"M Weischer","year":"2012","unstructured":"Weischer M, Nordestgaard BG, Pharoah P et al (2012) CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer. J Clin Oncol 30:4308\u20134316","journal-title":"J Clin Oncol"},{"key":"4181_CR24","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1200\/JCO.2014.57.1414","volume":"33","author":"FJ Couch","year":"2015","unstructured":"Couch FJ, Hart SN, Sharma P et al (2015) Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer. J Clin Oncol 33:304\u2013311","journal-title":"J Clin Oncol"},{"key":"4181_CR25","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1136\/jmedgenet-2012-100852","volume":"49","author":"LM Pelttari","year":"2012","unstructured":"Pelttari LM, Kiiski J, Nurminen R et al (2012) A Finnish founder mutation in RAD51D: analysis in breast, ovarian, prostate, and colorectal cancer. J Med Genet 49:429\u2013432","journal-title":"J Med Genet"},{"key":"4181_CR26","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/cncr.29058","volume":"121","author":"C Villarreal-Garza","year":"2015","unstructured":"Villarreal-Garza C, Alvarez-G\u00f3mez RM, P\u00e9rez-Plasencia C et al (2015) Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico. Cancer 121:372\u2013378","journal-title":"Cancer"},{"key":"4181_CR27","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s10549-009-0383-4","volume":"117","author":"D Torres","year":"2009","unstructured":"Torres D, Rashid MU, Colombian Breast Cancer Study Group (COLBCS) et al (2009) Absence of the BRCA1 del (exons 9\u201312) mutation in breast\/ovarian cancer families outside of Mexican Hispanics. Breast Cancer Res Treat 117:679\u2013681","journal-title":"Breast Cancer Res Treat"},{"key":"4181_CR28","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1158\/1055-9965.EPI-05-0072","volume":"14","author":"JN Weitzel","year":"2005","unstructured":"Weitzel JN, Lagos V, Blazer KR et al (2005) Prevalence of BRCA mutations and founder effect in high-risk Hispanic families. Cancer Epidemiol Biomark Prev 14:1666\u20131671","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"4181_CR29","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1158\/1055-9965.EPI-07-0198","volume":"16","author":"JN Weitzel","year":"2007","unstructured":"Weitzel JN, Lagos VI, Herzog JS et al (2007) Evidence for common ancestral origin of a recurring BRCA1 genomic rearrangement identified in high-risk Hispanic families. Cancer Epidemiol Biomark Prev 16:1615\u20131620","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"4181_CR30","doi-asserted-by":"publisher","first-page":"5210","DOI":"10.1002\/cncr.27556","volume":"118","author":"T Judkins","year":"2012","unstructured":"Judkins T, Rosenthal E, Arnell C et al (2012) Clinical significance of large rearrangements in BRCA1 and BRCA2. Cancer 118:5210\u20135216","journal-title":"Cancer"},{"key":"4181_CR31","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1200\/JCO.2011.41.0027","volume":"31","author":"JN Weitzel","year":"2013","unstructured":"Weitzel JN, Clague J, Martir-Negron A et al (2013) Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network. J Clin Oncol 31:210\u2013216","journal-title":"J Clin Oncol"},{"key":"4181_CR32","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1001\/jama.298.24.2869","volume":"298","author":"EM John","year":"2007","unstructured":"John EM, Miron A, Gong G et al (2007) Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial\/ethnic groups. JAMA 298:2869\u20132876","journal-title":"JAMA"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-017-4181-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-017-4181-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-017-4181-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T14:03:08Z","timestamp":1568901788000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-017-4181-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,9]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["4181"],"URL":"https:\/\/doi.org\/10.1007\/s10549-017-4181-0","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,9]]}}}